UGT2A2, or UDP glucuronosyltransferase family 2 member A2, is an enzyme that plays a critical role in the metabolism of a diverse array of compounds through the process of glucuronidation. This biochemical reaction primarily facilitates the transformation of small lipophilic molecules such as hormones, bilirubin, and various xenobiotics into more water-soluble glucuronides, which can be more easily excreted from the body. The UGT2A2 enzyme is part of a larger family of UGTs, each with a specific, yet sometimes overlapping, substrate specificity. The expression of UGT2A2 is tightly regulated within the body, ensuring that it is produced in response to the appropriate metabolic demands. The induction of UGT2A2 is not only a pivotal process for maintaining metabolic homeostasis but also a reflection of the body's adaptive response to increased levels of endogenous or exogenous compounds that require detoxification.
A variety of chemical compounds have been identified that can potentially induce the expression of UGT2A2. These activators often function through the activation of nuclear receptors, which are transcription factors that when bound by specific ligands, translocate to the nucleus and bind to DNA at promoter regions of target genes like UGT2A2. For instance, compounds such as phenobarbital and rifampicin are known to activate the constitutive androstane receptor (CAR) and pregnane X receptor (PXR), respectively. Both receptors, upon activation, can enhance the transcription of UGT2A2. Other compounds, including omeprazole and clofibric acid, interact with different xenobiotic-sensing nuclear receptors, leading to similar upregulation in expression. Additionally, compounds like dexamethasone demonstrate the complexity of this regulation by activating the glucocorticoid receptor, which also has implications for the expression of UGT2A2. Furthermore, natural substances such as chrysin and ellagic acid, commonly found in various fruits and vegetables, have been shown to stimulate the expression of UGT2A2 by engaging with cellular antioxidant response pathways. This induction reflects the intricate network of cellular defenses that ensure the body can effectively respond to and process a wide range of substances through enhanced glucuronidation capacity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin is known to stimulate the expression of UGT2A2 through the activation of the pregnane X receptor (PXR), which binds to response elements on DNA, initiating transcription. | ||||||
Omeprazole | 73590-58-6 | sc-202265 | 50 mg | $67.00 | 4 | |
Omeprazole can induce UGT2A2 expression by activating xenobiotic-responsive nuclear receptors, which enhance gene transcription involved in drug metabolism. | ||||||
Clofibric acid | 882-09-7 | sc-203000 sc-203000A | 10 g 50 g | $24.00 $40.00 | 1 | |
Clofibric acid can increase UGT2A2 levels by serving as a peroxisome proliferator-activated receptor alpha (PPARα) agonist, leading to the transcriptional activation of genes encoding for enzymes in the glucuronidation pathway. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone may induce the expression of UGT2A2 through its action as a glucocorticoid receptor agonist, promoting the transcription of genes that aid in metabolism and excretion of xenobiotics. | ||||||
Benzo[a]pyrene | 50-32-8 | sc-257130 | 1 g | $612.00 | 4 | |
Benzo[a]pyrene may upregulate UGT2A2 as an adaptive cellular response to oxidative stress caused by this polycyclic aromatic hydrocarbon, enhancing its conjugation and excretion. | ||||||
Chrysin | 480-40-0 | sc-204686 | 1 g | $38.00 | 13 | |
Chrysin can stimulate UGT2A2 expression through its interaction with various signal transduction pathways, leading to the transcription of genes involved in the metabolism of xenobiotics. | ||||||
Ellagic Acid, Dihydrate | 476-66-4 | sc-202598 sc-202598A sc-202598B sc-202598C | 500 mg 5 g 25 g 100 g | $58.00 $95.00 $245.00 $727.00 | 8 | |
Ellagic acid may upregulate the expression of UGT2A2 by activating the nuclear factor erythroid 2–related factor 2 (Nrf2), which is responsible for the antioxidant response and the expression of phase II detoxifying enzymes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can induce UGT2A2 expression by stimulating the Nrf2 pathway, which increases the transcription of genes encoding detoxification enzymes to neutralize reactive metabolites. | ||||||
Piperine | 94-62-2 | sc-205809 sc-205809A | 5 g 25 g | $37.00 $146.00 | 3 | |
Piperine may increase UGT2A2 expression by enhancing the bioavailability of co-administered substances, which can activate metabolic pathways to compensate for the increased xenobiotic load. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol has the potential to stimulate UGT2A2 expression through its action as an antioxidant, leading to the activation of pathways involved in cellular defense mechanisms against toxins. | ||||||